UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 2, 2024
Accession Number:
0001104659-24-075712
Submission Type:
POS AM
CIK:
0001173281
Company Name:
NeuBase Therapeutics, Inc.
File Number:
333-233767